Moreover, they discovered that AFAP1L1 induction facilitated epithelial-mesenchymal transition (EMT) to promote the advancement of gastric cancer by activating CDC42 and ITGA5 signaling pathways, with mediation from VAV2 [18]. Here, VAV2 is linked to gastric cancer.